A Prospective Observational Study Evaluating the Efficacy of Omalizumab and Mepolizumab in Patients With Severe Asthma.

Cureus · 2025 · PMC12709663 · PMID 41416315

Europe PMC DOI

hedged sentence

0.1290

closest p · 2.6× alpha

0.1290

boldest claim

The sentences

did not reach statistical significancep=0.129not close (p > 0.1)

While this suggests better preserved lung function in the omalizumab group, the difference did not reach statistical significance (t=1.53, p=0.129).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.